Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers

The findings call for mechanistic translational studies to understand these deleterious effects of dexmedetomidine, and warrant prospective clinical trials to assess the impact of perioperative dexmedetomidine use on outcomes in cancer patients.